Testosterone pellets (Testopel)

OFFICE ADMINISTRATION

Indications for Prior Authorization:

  • Primary hypogonadism
    • Testicular failure due to bilateral torsion, orchitis, vanishing testes syndrome, cryptorchidism, or orchidectomy
  • Hypogonadotrophic hypogonadism
  • LHRH deficiency, pituitary hypothalamic injury from tumors, trauma, or radiation
  • Male delayed puberty

The following indications do not meet the criteria for use established by the Western Health Advantage Pharmacy and Therapeutics Committee:

  • Treatment of female patients with symptoms of menopause or decreased libido
  • Palliation therapy in post-menopausal women with breast cancer
  • Any other diagnosis not listed in the approved indications
  • The drug is not approvable for use in men with breast or prostate cancer

All of the following must be met:

  • Treatment failure with topical and intramuscular testosterone administration
  • Failure is defined as the inability to achieve normal plasma testosterone levels

Dosing:

  • Pellet SC implantation 150 mg to 450 mg every 3-6 months

Approval: 

2 months


 

Last review date: July 10, 2018

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone